Transungual delivery of ketoconazole using novel lacquer formulation

International Journal of Pharmaceutics

Volumn 456, Issue 2, 2013, Pages 357-361

  Hafeez, Farhaan ^a   Hui, Xiaoying ^a   Chiang, Audris ^a   Hornby, Sidney ^b   Maibach, Howard ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNSON AND JOHNSON   (United States)

Author keywords

Human nail; In vitro; Ketoconazole; MIC; Onychomycosis; Topical formulation

Indexed keywords

KETOCONAZOLE; PAINT;

ANTIFUNGAL ACTIVITY; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CREAM; DRUG ABSORPTION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NAIL; NAIL BED; ONYCHOMYCOSIS; PRIORITY JOURNAL; RADIOACTIVITY; TOPICAL TREATMENT;

HUMAN NAIL; IN VITRO; KETOCONAZOLE; MIC; ONYCHOMYCOSIS; TOPICAL FORMULATION;

ANTIFUNGAL AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; HUMANS; KETOCONAZOLE; LACQUER; NAILS; ONYCHOMYCOSIS;

EID: 84886720046     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.08.082     Document Type: Article

References (25)

1. J.A. Balfour, and D. Faulds Terbinafine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses Drugs 43 1992 259 284
2. S.I. Cullen, and M.K. Cullen Ketoconazole and griseofulvin in the treatment of toenail dermatophyte onychomycosis Curr. Ther. Res. Clin. Exp. 41 1987 24 29 (Pubitemid 17029220)
3. Z.D. Draelos, S.R. Feldman, V. Butners, and A.B. Alió Saenz Long-term safety of ketoconazole foam 2% in the treatment of seborrheic dermatitis: results of a phase IV, open-label study J. Drugs Dermatol. 12 2013 e1 e6
4. I. Effendy, M. Lecha, M. Feuilhade de Chauvin, N. Di Chiacchio, R. Baran European Onychomycosis Observatory Epidemiology and clinical classification of onychomycosis J. Eur. Acad. Dermatol. Venereol. 19 2005 8 12 (Pubitemid 41726923)
5. B. Elewski, and A. Tavakkol Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality Ther. Clin. Risk Manag. 1 2005 299 306
6. R. Elkeeb, A. Alikhan, L. Elkeeb, X. Hui, and H.I. Maibach Transungual drug delivery: current status Int. J. Pharm. 384 2010 1 8
7. J. Faergemann, and R. Baran Epidemiology, clinical presentation and diagnosis of onychomycosis Br. J. Dermatol. 149 2003 1 4 (Pubitemid 37410063)
8. H.B. Gunt, and G.B. Kasting Effect of hydration on the permeation of ketoconazole through human nail plate in vitro Eur. J. Pharm. Sci. 32 2007 254 260 (Pubitemid 350051888)
9. A.K. Gupta, and Y. Kohli In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity Br. J. Dermatol. 149 2003 296 305 (Pubitemid 37100255)
10. A.K. Gupta, M. Uro, and E.A. Cooper Onychomycosis therapy: past, present, future J. Drugs Dermatol. 9 2010 1109 1113
11. M. Hall, C. Monka, P. Krupp, and D. O'Sullivan Safety of oral terbinafine: results of a postmarketing surveillance study in 25,884 patients Arch. Dermatol. 133 1997 1213 1219 (Pubitemid 27443813)
12. X. Hui, T.C. Chan, S. Barbadillo, C. Lee, H.I. Maibach, and R.C. Wester Enhanced econazole penetration into human nail by 2-n-nonyl-1,3-dioxolane J. Pharm. Sci. 92 2003 142 148 (Pubitemid 36042305)
13. X. Hui, Z. Shainhouse, H. Tanojo, A. Anigbogu, G.E. Markus, H.I. Maibach, and R.C. Wester Enhanced human nail drug delivery: nail inner drug content assayed by new unique method J. Pharm. Sci. 91 2002 189 195 (Pubitemid 34074477)
14. X. Hui, R.C. Wester, and H.I. Maibach Nail penetration B. Baran, H.I. Maibach, Textbook of Cosmetic Dermatology fourth ed. 2010 Informa Healthcare New York 63 72
15. C.A. Lyman, and T.J. Walsh Systemically administered antifungal agents: a review of their clinical pharmacology and therapeutic applications Drugs 44 1992 9 35
16. G.G. Malhotra, and J.L. Zatz Investigation of nail permeation enhancement by chemical modification using water as a probe J. Pharm. Sci. 91 2002 312 323 (Pubitemid 34137355)
17. J.L. Marty Amorolfine nail lacquer: a novel formulation J. Eur. Acad. Dermatol. Venereol. 4 1995 17 21
18. D. Monti, L. Saccomani, P. Chetoni, S. Burgalassi, S. Senesi, E. Ghelardi, and F. Mailland Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity Br. J. Dermatol. 162 2010 311 317
19. S. Murdan Drug delivery to the nail following topical application Int. J. Pharm. 236 2002 1 26 (Pubitemid 34219369)
20. H.N. Shivakumar, A. Juluri, B.G. Desai, and S.N. Murthy Ungual and transungual drug delivery Drug Dev. Ind. Pharm. 38 2012 901 911
21. N. Sun, Y. Xie, C. Sheng, Y. Cao, W. Zhang, H. Chen, and G. Fan In vivo pharmacokinetics and in vitro antifungal activity of iodiconazole, a new triazole, determined by microdialysis sampling Int. J. Antimicrob. Agents 41 2013 229 235
22. J. Thomas, G.A. Jacobson, C.K. Narkowicz, G.M. Peterson, H. Burnet, and C. Sharpe Toenail onychomycosis: an important global disease burden J. Clin. Pharm. Ther. 35 2010 497 519
23. J. Van Cutsem The antifungal activity of ketoconazole Am. J. Med. 24 1983 9 15
24. I. Vejnovic, L. Simmler, and G. Betz Investigation of different formulations for drug delivery through the nail plate Int. J. Pharm. 386 2010 185 194
25. K.A. Walters, H.M. Abdalghafor, and M.E. Lane The human nail - barrier characterisation and permeation enhancement Int. J. Pharm. 435 2012 10 21